Notice of Correction to Additional Information on Eligibility for PAR-16-113 "Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34)"

Notice Number: NOT-GM-16-101

Key Dates
Release Date:   March 3, 2016

Related Announcements
PAR-16-113

Issued by
National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to update the Additional Information on Eligibility for PAR-16-113  "Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34)".  Only one application per institution (normally identified by having a unique DUNS number) is allowed for the MARC U-STAR Program.

 

Part2. Section III.3. Additional Information on Eligibility

Current Language

Number of Applications

The NIH will not accept duplicate or highly overlapping applications under review at the same time.  This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).

New Language

Number of Applications

Only one application per institution (normally identified by having a unique DUNS number) is allowed for the MARC U-STAR Program.

The NIH will not accept duplicate or highly overlapping applications under review at the same time.  This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Alison Gammie, Ph.D.
National Institute of General Medical Sciences (NIGMS) 
Telephone: 301-594-3900
Email: alison.gammie@nih.gov

Richard Okita, Ph.D.
National Institute of General Medical Sciences (NIGMS) 
Telephone: 301-594-3900
Email:okitar@nigms.nih.gov